Cigna Group
- Tickers
- CI
- Headquarters
- Not recorded
- SEC CIK
- 0001739940
- Website
- Not recorded
Closing prices
Latest close, 298.41
| Date | Close |
|---|---|
| 258.62 | |
| 264.66 | |
| 259.58 | |
| 256.38 | |
| 264.58 | |
| 258.16 | |
| 268.00 | |
| 270.61 | |
| 270.89 | |
| 269.66 | |
| 271.33 | |
| 272.61 | |
| 271.99 | |
| 269.60 | |
| 278.09 | |
| 271.47 | |
| 278.20 | |
| 278.35 | |
| 277.28 | |
| 273.57 | |
| 274.10 | |
| 270.32 | |
| 268.42 | |
| 265.44 | |
| 263.54 | |
| 262.71 | |
| 262.60 | |
| 272.26 | |
| 274.70 | |
| 277.15 | |
| 276.11 | |
| 273.84 | |
| 274.00 | |
| 271.89 | |
| 275.60 | |
| 273.75 | |
| 274.86 | |
| 276.51 | |
| 276.01 | |
| 276.48 | |
| 275.23 | |
| 279.12 | |
| 283.97 | |
| 284.76 | |
| 279.12 | |
| 283.91 | |
| 278.95 | |
| 276.02 | |
| 271.81 | |
| 271.00 | |
| 277.94 | |
| 272.21 | |
| 271.24 | |
| 274.91 | |
| 280.39 | |
| 279.20 | |
| 280.41 | |
| 270.09 | |
| 272.38 | |
| 271.27 | |
| 274.11 | |
| 271.54 | |
| 275.39 | |
| 271.71 | |
| 284.53 | |
| 292.05 | |
| 294.40 | |
| 287.81 | |
| 294.73 | |
| 287.61 | |
| 291.44 | |
| 290.71 | |
| 290.12 | |
| 285.92 | |
| 280.31 | |
| 283.18 | |
| 281.00 | |
| 284.44 | |
| 288.82 | |
| 289.82 | |
| 290.85 | |
| 283.93 | |
| 284.74 | |
| 281.27 | |
| 271.63 | |
| 269.66 | |
| 262.44 | |
| 260.87 | |
| 265.88 | |
| 267.19 | |
| 268.35 | |
| 263.47 | |
| 264.61 | |
| 264.57 | |
| 262.84 | |
| 261.49 | |
| 265.87 | |
| 270.36 | |
| 272.08 | |
| 261.96 | |
| 258.08 | |
| 266.75 | |
| 267.32 | |
| 270.02 | |
| 275.69 | |
| 274.25 | |
| 277.56 | |
| 278.45 | |
| 271.25 | |
| 275.12 | |
| 272.60 | |
| 268.63 | |
| 276.37 | |
| 278.64 | |
| 279.92 | |
| 276.69 | |
| 274.70 | |
| 279.72 | |
| 275.64 | |
| 282.58 | |
| 284.92 | |
| 292.32 | |
| 290.58 | |
| 282.90 | |
| 279.35 | |
| 275.66 | |
| 281.98 | |
| 284.04 | |
| 288.06 | |
| 289.07 | |
| 298.49 | |
| 300.71 | |
| 294.93 | |
| 285.27 | |
| 286.69 | |
| 291.28 | |
| 283.10 | |
| 282.02 | |
| 286.24 | |
| 280.83 | |
| 285.75 | |
| 284.33 | |
| 277.40 | |
| 274.19 | |
| 272.72 | |
| 270.73 | |
| 280.68 | |
| 289.48 | |
| 289.61 | |
| 295.00 | |
| 295.81 | |
| 294.84 | |
| 298.00 | |
| 293.83 | |
| 291.88 | |
| 285.09 | |
| 279.27 | |
| 282.08 | |
| 283.08 | |
| 279.46 | |
| 281.87 | |
| 282.79 | |
| 278.74 | |
| 275.68 | |
| 277.07 | |
| 287.77 | |
| 281.98 | |
| 286.62 | |
| 289.73 | |
| 291.80 | |
| 293.46 | |
| 304.50 | |
| 303.35 | |
| 297.81 | |
| 283.82 | |
| 281.45 | |
| 283.94 | |
| 290.49 | |
| 284.85 | |
| 286.29 | |
| 289.57 | |
| 291.02 | |
| 301.06 | |
| 296.47 | |
| 287.66 | |
| 279.05 | |
| 282.06 | |
| 274.05 | |
| 270.50 | |
| 275.25 | |
| 282.49 | |
| 278.40 | |
| 273.87 | |
| 277.41 | |
| 277.99 | |
| 282.56 | |
| 275.33 | |
| 278.50 | |
| 277.45 | |
| 274.41 | |
| 277.51 | |
| 280.45 | |
| 279.32 | |
| 280.87 | |
| 277.67 | |
| 278.88 | |
| 276.08 | |
| 283.06 | |
| 282.84 | |
| 286.26 | |
| 282.52 | |
| 275.83 | |
| 278.17 | |
| 280.91 | |
| 280.76 | |
| 290.05 | |
| 288.90 | |
| 280.45 | |
| 276.00 | |
| 275.28 | |
| 274.47 | |
| 273.74 | |
| 268.27 | |
| 265.50 | |
| 272.01 | |
| 271.83 | |
| 275.26 | |
| 271.83 | |
| 267.96 | |
| 270.53 | |
| 271.29 | |
| 274.37 | |
| 278.51 | |
| 281.03 | |
| 282.43 | |
| 283.34 | |
| 282.53 | |
| 289.58 | |
| 298.81 | |
| 302.30 | |
| 298.50 | |
| 306.60 | |
| 304.37 | |
| 315.88 | |
| 306.95 | |
| 305.78 | |
| 298.28 | |
| 295.00 | |
| 298.41 |
Drugs
No drugs from this company are tracked yet.
FDA-approved applications
No Drugs@FDA application has a sponsor name that matches this company.
Data provided by the U.S. Food and Drug Administration (Drugs@FDA). Sponsors are matched to companies by name; subsidiaries do not link.
Catalysts
No catalysts yet. Editors add each date together with its source.
Deals
No approved deals involve this company yet.
Reported fundamentals (SEC XBRL)
| Metric | Reported value | Period | Filing |
|---|---|---|---|
| Revenue | 71,668,000,000 USD | 1 Apr 2026 to 30 Jun 2026 FY2026 Q2 | 10-Q for Revenue on sec.gov (opens in a new tab)Filed |
| Net income (loss) | 1,660,000,000 USD | 1 Apr 2026 to 30 Jun 2026 FY2026 Q2 | 10-Q for Net income (loss) on sec.gov (opens in a new tab)Filed |
| Research and development expense | Not reported in XBRL filings since 2015 | ||
| Operating expenses | Not reported in XBRL filings since 2015 | ||
| Cash and cash equivalents | 6,298,000,000 USD | At 30 Jun 2026 FY2026 Q2 | 10-Q for Cash and cash equivalents on sec.gov (opens in a new tab)Filed |
| Short-term investments and marketable securities | 959,000,000 USD | At 30 Jun 2026 FY2026 Q2 | 10-Q for Short-term investments and marketable securities on sec.gov (opens in a new tab)Filed |
| Total liabilities | 114,172,000,000 USD | At 30 Jun 2026 FY2026 Q2 | 10-Q for Total liabilities on sec.gov (opens in a new tab)Filed |
| Stockholders' equity | 42,620,000,000 USD | At 30 Jun 2026 FY2026 Q2 | 10-Q for Stockholders' equity on sec.gov (opens in a new tab)Filed |
| Common shares outstanding (cover page) | 264,240,486 shares | At 24 Jul 2026 FY2026 Q2 | 10-Q for Common shares outstanding (cover page) on sec.gov (opens in a new tab)Filed |
History
| Period | Reported value | Filing |
|---|---|---|
| 1 Apr 2026 to 30 Jun 2026 FY2026 Q2 | 71,668,000,000 USD | 10-Q filed 30 Jul 2026 on sec.gov (opens in a new tab)Filed |
| 1 Jan 2026 to 31 Mar 2026 FY2026 Q1 | 68,494,000,000 USD | 10-Q filed 30 Apr 2026 on sec.gov (opens in a new tab)Filed |
| 1 Jan 2025 to 31 Dec 2025 FY2025 | 274,900,000,000 USD | 10-K filed 26 Feb 2026 on sec.gov (opens in a new tab)Filed |
| 1 Jul 2025 to 30 Sep 2025 FY2025 Q3 | 69,748,000,000 USD | 10-Q filed 30 Oct 2025 on sec.gov (opens in a new tab)Filed |
| 1 Apr 2025 to 30 Jun 2025 FY2026 Q2 | 67,178,000,000 USD | 10-Q filed 30 Jul 2026 on sec.gov (opens in a new tab)Filed |
| 1 Jan 2025 to 31 Mar 2025 FY2026 Q1 | 65,502,000,000 USD | 10-Q filed 30 Apr 2026 on sec.gov (opens in a new tab)Filed |
| 1 Jan 2024 to 31 Dec 2024 FY2025 | 247,121,000,000 USD | 10-K filed 26 Feb 2026 on sec.gov (opens in a new tab)Filed |
| 1 Jul 2024 to 30 Sep 2024 FY2025 Q3 | 63,694,000,000 USD | 10-Q filed 30 Oct 2025 on sec.gov (opens in a new tab)Filed |
The newest 12 periods of each metric are listed; older ones are on sec.gov.
Values as reported in the company's XBRL filings to the SEC, one per calendar period (SEC frames); not adjusted, not audited by HealthTrade, and not investment advice.
Source: SEC XBRL company facts (opens in a new tab) · Licence: public-domain · as of 2026-10-25 · read
SEC filings
Source: SEC EDGAR. Each row links to the filing on sec.gov.
Related news
Insider transactions
All rows for Cigna Group on Insider TradesLast 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).
- Buys code P
- None in this period
- Sells code S
- 3 transactions, 22,730 shares, $6,293,358.54
- Other all other codes
- 3 transactions: grants, exercises, tax withholding, gifts and similar
Last transaction:
Insider filings are public records and are not a recommendation. Source: SEC EDGAR.
Sources
- Editor source (opens in a new tab) Licence: editorial. Entered by an editor, not fetched automatically
- SEC EDGAR submissions (opens in a new tab) Licence: public-domain. Fetched
Nothing on this page is investment advice.